↓ Skip to main content

Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults

Overview of attention for article published in Cochrane database of systematic reviews, July 2005
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
120 Dimensions

Readers on

mendeley
161 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults
Published in
Cochrane database of systematic reviews, July 2005
DOI 10.1002/14651858.cd004742.pub2
Pubmed ID
Authors

Paramananthan Mariappan, Ammar A Alhasso, Adrian Grant, James MO N'Dow

Abstract

To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 161 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 12%
Researcher 18 11%
Student > Ph. D. Student 17 11%
Student > Bachelor 16 10%
Unspecified 10 6%
Other 39 24%
Unknown 41 25%
Readers by discipline Count As %
Medicine and Dentistry 57 35%
Nursing and Health Professions 18 11%
Unspecified 10 6%
Psychology 7 4%
Social Sciences 5 3%
Other 16 10%
Unknown 48 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2022.
All research outputs
#17,348,916
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,493
of 11,499 outputs
Outputs of similar age
#61,814
of 69,215 outputs
Outputs of similar age from Cochrane database of systematic reviews
#35
of 39 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,215 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.